HCPCS Q2054 at University of Washington Medical Ctr
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
What University of Washington Medical Ctr publishes for this code: as an outpatient
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $596,290 – $1,764,180 | — |
| Medicare Advantage | $562,538 – $618,792 | — |
| Cash price | — | — |
| List price | — | — |
Bills to expect
The hospital’s fee is the price above. Doctors usually send their own bills. Their amounts here are what original Medicare allows in Seattle (King County) for 2026, and a private-plan estimate of 118% to 179% of that (the range found across studies of what insurers pay doctors). Those are estimates, not quotes.
| Bill | What it’s for | Original Medicare allows | Private plan estimate |
|---|---|---|---|
| Hospital's fee | The drug, per billing unit | — | The price above |
Compare HCPCS Q2054 at every Washington hospital, with Medicare’s reference amounts.